TVARDI THERAPEUTICS, INC. Cash and Cash Equivalents
TVARDI THERAPEUTICS, INC. (TVRD) had Cash and Cash Equivalents of $15.77 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $15.77M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $19.85M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $20.73M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $21.42M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $15.77M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $19.85M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $20.73M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $21.42M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $20.65M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $34.22M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $31.61M 10-K · filed 2026-03-31 | $37.90M 10-K · filed 2025-03-11 |
| 2024-09-30 | $37.06M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $49.24M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $47.00M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $51.77M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $62.88M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $58.25M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $47.39M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $63.74M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $42.81M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $46.72M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $21.36M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $13.45M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $22.99M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $22.34M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $22.52M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $31.68M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $75.28M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $56.97M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $17.04M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $18.30M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $34.70M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $18.49M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $14.19M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $15.08M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $96.73M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $17.80M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $11.88M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $9.39M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $11.79M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $9.42M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $5.31M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $12.09M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $5.43M 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $3.54M 10-Q · filed 2017-08-03 | |
| 2016-03-31 | $7.92M 10-Q · filed 2017-05-04 | |
| 2015-12-31 | $15.10M 10-K · filed 2018-03-15 | |
| 2015-09-30 | $111.12M 10-Q · filed 2016-11-04 | |
| 2015-06-30 | $43.19M 10-Q · filed 2016-08-04 | |
| 2015-03-31 | $47.42M 10-Q · filed 2016-05-05 | |
| 2014-12-31 | $52.66M 10-K · filed 2018-03-15 | |
| 2014-09-30 | $58.39M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $62.81M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $67.04M 10-Q · filed 2015-05-12 | |
| 2013-12-31 | $12.36M 10-K · filed 2017-03-10 | |
| 2013-09-30 | $17.73M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $21.18M 10-Q · filed 2014-08-07 | |
| 2013-03-31 | $690.00K 10-Q · filed 2014-05-12 | |
| 2012-12-31 | $1.12M 10-K · filed 2016-03-11 | |
| 2011-12-31 | $4.10M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |